Skip to search formSkip to main contentSkip to account menu

Glucagon-Like Peptide Receptors

Known as: Receptors, Glucagon-Like, Glucagon-Like Receptors, Glucagon Like Peptide Receptors 
G-PROTEIN COUPLED CELL SURFACE RECEPTORS that bind GLUCAGON-LIKE PEPTIDES and are expressed by cells in pancreatic, intestinal, and neural tissues… 
National Institutes of Health

Related topics

Related topics

5 relations
In Bloodagonistsantagonists & inhibitorsaspects of radiation effects

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.
BACKGROUND & AIMS Postprandial glycemia excursions increase after gastric bypass surgery; this effect is even greater among… 
Highly Cited
2011
Highly Cited
2011
Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function
Central administration of glucagon-like peptide-1 (GLP-1) causes a dose-dependent reduction in food intake, but the role of… 
Highly Cited
2009
Highly Cited
2009
Prospective Study of Gut Hormone and Metabolic Changes After Adjustable Gastric Banding and Roux-en-Y Gastric Bypass
Objective:The objective of this study was to quantify hormones that regulate energy and glucose homeostasis to establish possible… 
Review
2008
Review
2008
Gastrointestinal satiety signals.
The increasing prevalence of obesity worldwide has imparted renewed impetus to the study of the mechanisms of appetite regulation… 
Highly Cited
2004
Highly Cited
2004
Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.
Glucagon-like peptide-1-(7-36)-amide (GLP-1) is involved in satiety control and glucose homeostasis. Animal studies suggest a… 
Review
2004
Review
2004
Therapeutic strategies based on glucagon-like peptide 1.
Glucagon-like peptide (GLP)-1 is an incretin hormone with potent glucose-dependent insulinotropic and glucagonostatic actions… 
Highly Cited
2003
Highly Cited
2003
Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
Glucagon-like peptide-1(7-36)-amide (GLP-1) is an endogenous insulinotropic peptide that is secreted from the gastrointestinal… 
Highly Cited
2002
Highly Cited
2002
Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.
Glucagon-like peptide-1 (GLP-1) is an intestinal incretin hormone, derived from the processing of proglucagon, that exerts… 
Highly Cited
1996
Highly Cited
1996
Gastric emptying and release of incretin hormones after glucose ingestion in humans.
This study investigated in eight healthy male volunteers (a) the gastric emptying pattern of 50 and 100 grams of glucose; (b) its… 
Highly Cited
1993
Highly Cited
1993
Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)
NON-INSULIN-DEPENDENT diabetes mellitus (NIDDM, type 2 diabetes) is a disorder of glucose homeostasis characterized by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)